Fundraising FoxRA Capital — 2018 Investments
9 investments dated 2018 · listed companies and verified rows first · show all
Prothena is a clinical-stage biotechnology company developing investigational therapies for neurodegenerative and rare peripheral amyloid diseases by targeting misfolded proteins.
BiotechDun Laoghaire, Co. Dublin, US
Tran B. Nguyen(Executive Officer)Arthur W. Homan(Executive Officer)Karin L. Walker(Executive Officer)inTara Nickerson, Ph.D.(Executive Officer)Wagner M. Zago, Ph.D.(Executive Officer)Carol D. Karp(Executive Officer)in
Co-investorsSofinnova VenturesInvescoWellington Management
Akouos is a precision genetic medicine company developing therapies for the inner ear to restore, improve, and preserve hearing.
BiotechHealthtechBrookline, US
Emmanuel Simons(Executive Officer, Director)william sewell(Founder)in
BoardEd Mathers(Director)inKush Parmar(Director)in
Co-investors5AM VenturesEcoR1 CapitalNew Enterprise Associates (NEA)Pivotal Life SciencesSofinnova VenturesCowen Healthcare Investments+2 more
A digital health resource platform providing medical professionals with educational information and clinical resources about transthyretin amyloid cardiomyopathy (ATTR-CM) and related cardiac and neurological conditions.
BiotechDigital HealthHealthtechSan Francisco, US
NEIL KUMAR(Executive Officer, Director)JONATHAN FOX(Executive Officer)UMA SINHA(Executive Officer)CHRISTINE SIU(Executive Officer)HOYOUNG HUH(Director)ERIC AGUIAR(Director)
Co-investorsAisling CapitalForesite CapitalViking GlobalViking Global Investors
TeraPore develops nanofiltration products based on tunable self-assembled block copolymer technology to address complex separation challenges in biopharmaceutical production and semiconductor manufacturing.
Advanced ManufacturingBiotechDeep TechNew MaterialsSemiconductorsSouth San Francisco, US
Rachel M. Dorin(Executive Officer, Director)inRachel Dorin(CTO and Founder)inMani Krishnan(President and CEO)in
BoardStuart Berkowitz(Director)David Seldin(Director)David Michael(Director)in
Co-investorsAnzu PartnersArtiman Ventures
Ventus AI is an enterprise automation platform offering AI agents ("AI teammates") that operate inside existing systems—desktop apps, web portals, and legacy software—without API integrations to automate complex business workflows, handling MFA, CAPTCHAs, and phone calls.
AI & Machine LearningEnterprise SoftwareHealthtechCasa Grande, US
Maran Vedamanikam(CEO and Manager)Peter Qian(Co-founder & CEO)Vincent Lu(Co-founder & CTO)
Co-investorsSamsung NextAndreessen HorowitzWndrCoAlexandriaBiotechnology Value FundCasdin Capital+5 more
Windward delivers AI-powered operational intelligence for maritime security and commercial applications, fusing behavioral analytics and multi-sensor data to detect threats and opportunities.
AI & Machine LearningData & InfrastructureDefense TechTel Aviv
Amiad Daniel(Executive Officer, Director)Matan Peled(Founder)inAmi Daniel(Founder)
BoardDov Gatmon(Director)Patrick Poon(Director)Eden Shochat(Director)in
Co-investorsAlephFTV CapitalThompson Hutton, LLCJanus Henderson InvestorsPivotal Life SciencesQiming Venture Partners+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.